DE19904397A1 - Verwendung von Pyrazol-Carbonsäureamiden - Google Patents

Verwendung von Pyrazol-Carbonsäureamiden

Info

Publication number
DE19904397A1
DE19904397A1 DE19904397A DE19904397A DE19904397A1 DE 19904397 A1 DE19904397 A1 DE 19904397A1 DE 19904397 A DE19904397 A DE 19904397A DE 19904397 A DE19904397 A DE 19904397A DE 19904397 A1 DE19904397 A1 DE 19904397A1
Authority
DE
Germany
Prior art keywords
general formula
pyrazolecarboxamides
anemia
compounds
meaning given
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19904397A
Other languages
German (de)
English (en)
Inventor
Juergen Stoltefus
Gabriele Braeunlich
Berthold Hinzen
Thomas Kraemer
Josef Pernerstorfer
Thomas Stuedemann
Ulrich Nielsch
Martin Bechem
Emanuel Lohrmann
Christoph Gerdes
Michael Sperzel
Klemens Lustig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to DE19904397A priority Critical patent/DE19904397A1/de
Priority to AU31503/00A priority patent/AU3150300A/en
Priority to EP00909096A priority patent/EP1148879A2/de
Priority to CA002361636A priority patent/CA2361636A1/en
Priority to JP2000597013A priority patent/JP2002536348A/ja
Priority to PCT/EP2000/000519 priority patent/WO2000045894A2/de
Priority to ARP000100428A priority patent/AR022470A1/es
Priority to GT200000009A priority patent/GT200000009A/es
Publication of DE19904397A1 publication Critical patent/DE19904397A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE19904397A 1999-02-04 1999-02-04 Verwendung von Pyrazol-Carbonsäureamiden Withdrawn DE19904397A1 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
DE19904397A DE19904397A1 (de) 1999-02-04 1999-02-04 Verwendung von Pyrazol-Carbonsäureamiden
AU31503/00A AU3150300A (en) 1999-02-04 2000-01-24 Use of pyrazole carboxamides
EP00909096A EP1148879A2 (de) 1999-02-04 2000-01-24 Verwendung von pyrazol-carbonsäureamiden
CA002361636A CA2361636A1 (en) 1999-02-04 2000-01-24 Use of pyrazole carboxamides
JP2000597013A JP2002536348A (ja) 1999-02-04 2000-01-24 ピラゾールカルボキサミドの使用
PCT/EP2000/000519 WO2000045894A2 (de) 1999-02-04 2000-01-24 Verwendung von pyrazol-carbonsäureamiden
ARP000100428A AR022470A1 (es) 1999-02-04 2000-02-01 Uso de pirazol-carboxamidas
GT200000009A GT200000009A (es) 1999-02-04 2000-02-03 Uso de pirazol-carboxamidas.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19904397A DE19904397A1 (de) 1999-02-04 1999-02-04 Verwendung von Pyrazol-Carbonsäureamiden

Publications (1)

Publication Number Publication Date
DE19904397A1 true DE19904397A1 (de) 2000-08-10

Family

ID=7896339

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19904397A Withdrawn DE19904397A1 (de) 1999-02-04 1999-02-04 Verwendung von Pyrazol-Carbonsäureamiden

Country Status (8)

Country Link
EP (1) EP1148879A2 (ja)
JP (1) JP2002536348A (ja)
AR (1) AR022470A1 (ja)
AU (1) AU3150300A (ja)
CA (1) CA2361636A1 (ja)
DE (1) DE19904397A1 (ja)
GT (1) GT200000009A (ja)
WO (1) WO2000045894A2 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4173485A1 (en) * 2021-10-27 2023-05-03 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Protein aggregation inhibiting compounds for plant disease control

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878729B2 (en) * 2001-05-04 2005-04-12 The Procter & Gamble Company Medicinal uses of dihydropyrazoles
US8710038B2 (en) 2004-09-17 2014-04-29 Exelixis, Inc. Pyrazole kinase modulators and methods of use
UY30892A1 (es) 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt
US20110288142A1 (en) 2009-01-30 2011-11-24 Chen Pingyun Y CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
US5434178A (en) * 1993-11-30 1995-07-18 G.D. Searle & Co. 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation
WO1997019039A1 (en) * 1995-11-17 1997-05-29 Novartis Ag Solid phase synthesis of heterocyclic compounds and combinatorial compound library
DE19904406A1 (de) * 1999-02-04 2000-08-10 Bayer Ag Substituierte Pyrazolcarbonsäuren
DE19904396A1 (de) * 1999-02-04 2000-08-10 Bayer Ag Substituierte Pyrazolbenzylamin-Derivate

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4173485A1 (en) * 2021-10-27 2023-05-03 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Protein aggregation inhibiting compounds for plant disease control
WO2023073115A1 (en) * 2021-10-27 2023-05-04 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Protein aggregation inhibiting compounds for plant disease control

Also Published As

Publication number Publication date
AU3150300A (en) 2000-08-25
EP1148879A2 (de) 2001-10-31
GT200000009A (es) 2001-07-27
WO2000045894A2 (de) 2000-08-10
WO2000045894A3 (de) 2001-04-19
JP2002536348A (ja) 2002-10-29
AR022470A1 (es) 2002-09-04
CA2361636A1 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
DE19904389A1 (de) Verwendung von substituierten Isoxazolcarbonsäuren und Derivate und neue Stoffe
DE3630903A1 (de) Neue tetrahydronaphthalin- und indanderivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
DE19904397A1 (de) Verwendung von Pyrazol-Carbonsäureamiden
EP0749970A1 (de) Benzisothiazolyl-substituierte Aminomethylchromane
WO1992011010A1 (de) Neue 3,4-dihydroisochinolinderivate und neue pharmazeutische verwendung carbocyclisch und heterocyclisch anellierter dihydropyridine
DE19904406A1 (de) Substituierte Pyrazolcarbonsäuren
DE68902064T2 (de) Dihydropyridine und ihre verwendung als anti-allergische und entzuendungshemmende mittel.
WO1996002547A1 (de) Dioxo-thiopyrano-pyridin-carbonsäure-derivate und ihre verwendung als arzneimittel
DE19904396A1 (de) Substituierte Pyrazolbenzylamin-Derivate
DE2549568A1 (de) 2,6-dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsaeureisobutylester, mehrere verfahren zu seiner herstellung sowie seine verwendung als coronartherapeutikum
DE10010423A1 (de) Substituierte 2,5-Dimethyldihydropyridazinone und ihre Verwendung
DE19904391A1 (de) Pyrazol-Alkylamide
WO2001000601A1 (de) 4-(2-oxodihydrooxadiazinylphenyl)amide und ihre verwendung zur bekämpfung von anämien
EP1432686B1 (de) Tetrahydroisochinoline, ihre herstellung und verwendung als schmerzmittel
EP0891322B1 (de) Dimethyl-substituierte cyclohexandienderivate
EP1196392A1 (de) 6-carboxyphenyldihydropyridazinon-derivate und ihre verwendung
DE3640829A1 (de) Neue 1-aryloxy-3-amino-2-propanole, ihre herstellung und verwendung
EP1047685A1 (de) Substituierte beta,gamma-anellierte lactone
WO2001000598A1 (de) N-[4-(6-oxotetrahydrotriazinyl)phenyl]amide und ihre verwendung
EP1196173A2 (de) Tetrahydrochinolinyl-6-methyldihydrothiadiazinon-derivate und ihre verwendung zur prophylaxe und/oder behandlung von anämien
DE10010429A1 (de) Neue 6-[4-Sulfonamidophenyl]-dihydropyridazinone und ihre Verwendung
WO2001000590A1 (de) Substituierte 6-[4-(oxymethyl)-phenyl]-dihydropyridazinone und ihre verwendung
AT389310B (de) Cyclohexandion-derivat und verfahren zu seiner herstellung
DE19629145A1 (de) Verwendung von Triphenylmethyl-1,2,3-triazolen
EP0274124A1 (de) Tetrahydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee